In April, trading turnover on the Swiss stock exchange was up 2.3% on the previous month and reached CHF 121.8 billion. There was also an increase in the number of transactions by 7.1% to 4,665,486. In comparison with the corresponding period last year, trading turnover was down by -5.5% at CHF 469.9 billion, while the number of trades dropped by -17.9% to 17,968,469. Since the beginning of the year, the SMI® rose by 15.9% and reached a new all-time high of 9769.74 points on 30 April.
- Trading turnover of CHF 121.8 billion (+2.3% month-on-month)
- Number of trades 4,665,486 (+7.1% month-on-month)
- SMI® index at 9769.7 points at the end of April (+3.1% month-on-month)
The highest turnover on a single trading day was recorded on 17 April, which saw securities worth a total volume of CHF 8.8 billion changing hands. The highest number of trades was recorded on 12 April, with 242,364 transactions. The stock that generated the highest turnover and highest number of transactions during the reporting month was NOVARTIS N with CHF 10.2 bn and 321,591 transactions.
In April, 24 products with crypto currencies as underlying were traded on the Swiss stock exchange. With a total of 1,303 trades, turnover reached CHF 28.1 million – in both cases more than doubling the numbers of the previous month. The most traded product, ZXBTAV, with Bitcoin as underlying, recorded a turnover of CHF 9.1 million with 354 transactions. A new product on the crypto currency Ripple (AXRP) was listed during this period.
|
Since beginning of 2019 |
Trading days since beginning of 2019: 82 |
Trading days in same prior-year period: 82 |
|---|---|---|
|
Segment |
Turnover in CHF million |
Change versus same prior-year period |
|
Equities incl. Funds + ETPs* |
370'366 |
-8.3% |
|
Bonds CHF |
41'509 |
-1.0% |
|
ETFs |
36'205 |
-6.3% |
|
Bonds non-CHF |
15'977 |
115.3% |
|
Structured products and warrants |
5'830 |
5.8% |
|
TOTAL |
469'887 |
-5.5% |
|
|
Number of trades |
Change versus same prior-year period |
|
Equities incl. Funds + ETPs* |
17'328'950 |
-17.9% |
|
Bonds CHF |
113'463 |
-7.1% |
|
ETFs |
350'687 |
-12.5% |
|
Bonds non-CHF |
8'422 |
48.4% |
|
Structured products and warrants |
166'947 |
-30.3% |
|
TOTAL |
17'968'469 |
-17.9% |
|
Number of newly listed products |
Change versus same prior-year period |
|
|
Bonds CHF |
111 |
13.3% |
|
Structured products and warrants |
13'694 |
7.3% |
*Contains domestic & foreign shares, investment funds, sponsored funds, ETSFs and ETPs
|
April 2019 |
Trading days April 2019: 20 |
Trading days in previous month: 21 |
|---|---|---|
|
Segment |
Turnover in CHF million |
Change versus previous month |
|
Equities incl. Funds + ETPs* |
99'862 | -0.5% |
|
Bonds CHF |
10'812 | 16.5% |
|
ETFs |
7'641 | 18.8% |
|
Bonds non-CHF |
2'524 | 31.7% |
|
Structured products and warrants |
947 | -13.5% |
|
TOTAL |
121'786 | 2.3% |
|
|
Number of trades |
Change versus previous month |
|
Equities incl. Funds + ETPs* |
4'505'656 | 7.3% |
|
Bonds CHF |
27'339 | 2.0% |
|
ETFs |
89'511 | 2.8% |
|
Bonds non-CHF |
1'556 | -9.4% |
|
Structured products and warrants |
41'424 | 1.0% |
|
TOTAL |
4'665'486 | 7.1% |
|
Number of newly listed products |
Change versus previous month |
|
|
Bonds CHF |
29 |
-14.7% |
|
Structured products and warrants |
3'465 |
-0.3% |
*Contains domestic & foreign shares, investment funds, sponsored funds, ETSFs and ETPs
|
Index |
Month-end reading |
Change versus end of previous month |
Change since end of 2018 |
|---|---|---|---|
|
SMI® PR |
9'769.7 |
3.1% |
15.9% |
|
SLI Swiss Leader Index® PR |
1'528.2 |
5.3% |
17.9% |
|
SMIM® PR |
2'552.3 |
5.4% |
21.4% |
|
SPI® TR |
11'735.2 |
4.4% |
19.4% |
|
SPI EXTRA® TR |
4'265.9 |
6.2% |
19.9% |
|
SXI LIFE SCIENCES® TR |
5'034.4 |
2.1% |
21.6% |
|
SXI Bio+Medtech® TR |
4'475.0 |
3.2% |
20.5% |
|
SBI® AAA-BBB Total Return |
138.6 |
-0.3% |
1.6% |
